Biotech company
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | BRIDGEBIO PHARMA, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$500,000 | |
| 2026 | BRIDGEBIO PHARMA, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$420,000 | |
| 2025 | BRIDGEBIO PHARMA, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$270,000 | |
| 2025 | BRIDGEBIO PHARMA, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$270,000 | |
| 2025 | BRIDGEBIO PHARMA, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$320,000 | |
| 2025 | BRIDGEBIO PHARMA, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$320,000 | |
| 2024 | BRIDGEBIO PHARMA, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$320,000 | |
| 2024 | BRIDGEBIO PHARMA, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$170,000 | |
| 2024 | BRIDGEBIO PHARMA, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$170,000 | |
| 2024 | BRIDGEBIO PHARMA, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$150,000 |
| Firm | Filings | Expenses |
|---|---|---|
| BRIDGEBIO PHARMA, INC. | 12 | $3,030,000 |
| Issue | Activities |
|---|---|
| Pharmacy | 11 |
| Health Issues | 1 |